MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Interventions"

  • 2025 International Congress

    Developing a Smartphone Application to Capture Objective Smartwatch Passive and Continuous Data to Individualize Parkinson’s Disease Patient Care

    J. Jones, A. Sukhija-Cohen, J. Liu, R. Chapman, K. Karuturi, D. Mitchell, M. Bhanushali (Walnut Creek, USA)

    Objective: To describe a large health care organization’s process to develop a Parkinson’s Disease (PD) smartphone application (app) to provide individualized care to patients. Background:…
  • 2025 International Congress

    Aquatic Interval Training in Individuals with Parkinson’s Disease: Can It Improve Gait?

    T. Christinelli, G. Leveck, L. Paladini, S. Souza, V. Israel (Curitiba, Brazil)

    Objective: To identify changes in gait speed and gait-related activities after an aquatic interval training physiotherapy program in individuals with PD. Background: Parkinson's disease (PD)…
  • 2025 International Congress

    Understanding Referral Patterns to a Pediatric Movement Disorders Clinic: A Quality Improvement Project

    A. Leblanc-Millar, C. Gorodetsky (Toronto, Canada)

    Objective: To implement a Quality Improvement initiative analyzing referral patterns to an Ontario pediatric movement disorder clinic to develop a better understanding of the acceptance,…
  • 2025 International Congress

    Effect of CUE1+ Device on Motor and Non-Motor Symptoms in Parkinson’s: A Pilot Randomised Controlled Trial.

    V. Azoidou, K. Rowsell, E. Camboe, K. Dey, A. Zirra, C. Quah, T. Boyle, C. Budu, D. Gallagher, A. Noyce, C. Simonet (London, United Kingdom)

    Objective: To assess the effect CUE1+ device on motor and non-motor symptoms in people with Parkinson’s (PwP). Background: Current treatments for PwP often fail to…
  • 2024 International Congress

    Exercise-induced angiogenesis and midbrain neuroprotection in a mouse model of experimental PD

    T. Rodriguez, R. Smeyne, M. Smeyne (Philadelphia, USA)

    Objective: The goal of this study is to characterize microvascular changes in the SNpc in response to a neuroprotective bout of exercise. Background: Parkinson’s disease…
  • 2024 International Congress

    Assessing Feasibility of Using Phone Video Data in Diagnosing Parkinsonism

    Z. Ahmed, S. Desai, A. Deb, S. Roy, D. Desai (Worcester, USA)

    Objective: This project aims to address potential gaps in rural healthcare by assessing the feasibility of using mobile phone data to identify features of parkinsonism…
  • 2024 International Congress

    Safety and Tolerability of Bemdaneprocel in People With Parkinson’s Disease: Results up to 24 Months From a Phase 1 Study

    H. Sarva, C. Henchcliffe, A. Lozano, A. Fasano, S. Kalia, K. Yu, C. Brennan, W. Stemple, N. Abid, M. Yountz, A. Enayetallah, A. Lampron, V. Tabar (New York, USA)

    Objective: To report the safety and tolerability of bemdaneprocel in participants with Parkinson’s disease (PD) up to 24 months post transplantation. Background: Bemdaneprocel is an…
  • 2024 International Congress

    Hospital Care Learning Collaborative: Sharing strategies to address the Parkinson’s Foundation Inpatient Clinical Care Standards

    A. Brooks, E. Buetow, H. Azmi, B. Walter, K. Amodeo, P. Pronovost (Miami, USA)

    Objective: The Parkinson’s Foundation made another significant step toward its vision to eliminate preventable harm and promote higher reliability in care with the launch of…
  • 2024 International Congress

    Motor and Non-Motor Outcomes of Bemdaneprocel in People With Parkinson’s Disease: Results up to 24 Months From a Phase 1 Study

    C. Henchcliffe, H. Sarva, A. Lozano, A. Fasano, S. Kalia, K. Yu, C. Brennan, W. Stemple, N. Abid, M. Yountz, A. Enayetallah, A. Lampron, V. Tabar (Orange, USA)

    Objective: To describe the effects of bemdaneprocel on motor and non-motor outcomes in participants with Parkinson’s disease (PD) up to 24 months post transplantation (12…
  • 2024 International Congress

    Feasibility of a Web Application to Enable Social Interaction in the PREDICT-PD Cohort

    L. Smith, X. Li, A. Gill, P. Panzarasa, J. Bestwick, A. Schrag, A. Noyce, A. de Simoni (London, United Kingdom)

    Objective: This study aims to:(1) Explore the feasibility of delivering a web application to enable social interaction and analyse digital social characteristics.(2) Gather insights into…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 29
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley